Breakthrough Innovation Keeps Heart Patients Alive

Vitaria, a division of LivaNova, was the first to pioneer the treatment of chronic heart failure with an implantable heart device that restores the balance of sympathetic and parasympathetic activity. Working with the most passionate and brilliant researchers, scientists, and physicians in the world, we helped launch this innovative heart device in Germany. We meticulously defined and laid out the content strategy on the website to where audiences could easily follow the evolution of this extraordinary procedure for heart failure like a story – from disease progression to how Vitaria solves the unmet needs of this disease, the procedure itself and what it entails.

Bringing the Evolutionary Procedure to Life

Vitaria Delivers ART

VITARIA is an Autonomic Regulation Therapy (ART) system that promotes autonomic balance in chronic heart failure patients.